CTAG2: A Potential Drug Target and Biomarker (G30848)

Target Name: CTAG2

NCBI ID: G30848

CTAG2

CTAG2: A Potential Drug Target and Biomarker

CTAG2 (C terminal transferase II) is a gene that encodes a protein known as CTAG2. The CTAG2 gene is located on chromosome 19 and has been implicated in the development and progression of various diseases, including cancer.

One of the key features of CTAG2 is its role in the regulation of cell growth and differentiation. The protein encoded by CTAG2 is involved in the transfer of genetic information from the cell's DNA to the cell's RNA during the process of transcription. This protein has been shown to play a crucial role in the regulation of cell proliferation and has been linked to the development of cancer.

In addition to its role in cell growth and differentiation, CTAG2 has also been shown to play a key role in the regulation of cell death. The protein encoded by CTAG2 has been shown to be involved in the regulation of cell apoptosis, which is the process by which cells die and are removed from the body. This protein has been linked to the development of various diseases, including cancer, and may be a potential drug target.

Another important function of CTAG2 is its role in the regulation of cell signaling pathways. The protein encoded by CTAG2 is involved in the regulation of several signaling pathways, including the TGF-β pathway and the NF-kappa-B pathway. These pathways are involved in the regulation of cell growth, differentiation, and inflammation.

In addition to its role in cell signaling pathways, CTAG2 has also been shown to play a key role in the regulation of cell adhesion. The protein encoded by CTAG2 is involved in the regulation of cell-cell adhesion and has been shown to play a crucial role in the development of cancer.

The potential drug target for CTAG2 is its role in the regulation of cell growth and differentiation, as well as its involvement in cell signaling pathways and cell adhesion. These functions make CTAG2 an attractive target for drug development, particularly for the treatment of diseases that are characterized by the uncontrolled growth and proliferation of cells.

Protein Name: Cancer/testis Antigen 2

The "CTAG2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CTAG2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets